Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
EVH holding history
Evolent Health, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EVH overviewAll 13F holders of EVHFull Q2 2026 holdings
- Shares (Q2 2026)
- 71,000
- Value
- $384.8K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 71,000 | $384.8K | <0.1% | −2,100−2.9% | Reduced | Holders |
| Q1 2026 | 73,100 | $166.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 73,100 | $292.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 73,100 | $618.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 73,100 | $823.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 73,100 | $691.5K | <0.1% | +73,100 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −73,101−100.0% | Sold out | Holders |
| Q3 2024 | 73,101 | $2.07M | <0.1% | +73,101 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −40,492−100.0% | Sold out | Holders |
| Q1 2024 | 40,492 | $1.33M | <0.1% | +40,492 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −15,157−100.0% | Sold out | Holders |
| Q3 2023 | 15,157 | $412.7K | <0.1% | +15,157 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −2,611−100.0% | Sold out | Holders |
| Q1 2023 | 2,611 | $84.7K | <0.1% | −20,000−88.5% | Reduced | Holders |
| Q4 2022 | 22,611 | $634.9K | <0.1% | +22,611 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −7,059−100.0% | Sold out | Holders |
| Q1 2022 | 7,059 | $228.0K | <0.1% | −163−2.3% | Reduced | Holders |
| Q4 2021 | 7,222 | $200.0K | <0.1% | −1,822−20.1% | Reduced | Holders |
| Q3 2021 | 9,044 | $280.0K | <0.1% | +9,044 | New | Holders |